Acrospire Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-3,520
Closed -$136K 449
2017
Q2
$136K Buy
3,520
+1,383
+65% +$50.6K 0.13% 104
2017
Q1
$73K Sell
2,137
-2,891
-57% -$94.9K 0.06% 573
2016
Q4
$165K Sell
5,028
-377
-7% -$12.2K 0.07% 516
2016
Q3
$174K Buy
5,405
+754
+16% +$24.4K 0.12% 214
2016
Q2
$144K Buy
4,651
+1,131
+32% +$35.4K 0.11% 213
2016
Q1
$105K Buy
+3,520
New +$97.2K 0.07% 291

Other funds holding EHC

Acrospire Investment Management's EHC Position: Q3 2017 in Review

Acrospire Investment Management sold out of Encompass Health (EHC) in Q3 2017, closing a stake of 3,520 shares — an estimated $136K sold.

Acrospire Investment Management first reported a position in EHC in Q1 2016 and held it in 6 quarters. The position peaked at $174K in Q3 2016. 323 funds tracked by Wall St. Rank hold EHC as of Q3 2017.

  • Acrospire Investment Management reported no remaining Encompass Health position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 3,520 Encompass Health shares in Q3 2017, an estimated $136K.
  • Acrospire Investment Management first reported a position in Encompass Health in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Encompass Health position peaked at $174K in Q3 2016.
  • 323 funds tracked by Wall St. Rank held Encompass Health as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.